Ethyl Isoxazol-3-carboxylate has been used as a reactant in the preparation of demethyl 2-amino-3-(3-carboxy-5-methyl-4-isoxazolyl)propionic acid (ACPA) which shows activity at metabotropic receptors and is a weak antagonist at the mGlu2 receptor subtype.